Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Qiagen N.V.
(NY:
QGEN
)
41.51
+0.06 (+0.14%)
Official Closing Price
Updated: 4:10 PM EST, Dec 4, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
781,135
Open
41.43
Bid (Size)
16.62 (2)
Ask (Size)
48.19 (1)
Prev. Close
41.45
Today's Range
41.26 - 41.67
52wk Range
34.74 - 51.18
Shares Outstanding
227,985,334
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Analyst Expectations for Qiagen's Future
November 02, 2023
Via
Benzinga
Diagnostic Firm Qiagen's Q3 Earnings: Analyst Says Annual Projections Attainable Despite Macro Trends
October 31, 2023
Qiagen NV's (NASDAQ: QGEN) Q3 net sales of $470 million at constant exchange rates (CER) for Q3 2023 were above the outlook for at least $465 million CER, driven by 5% CER growth in the
Via
Benzinga
Performance
YTD
-16.86%
-16.86%
1 Month
+5.89%
+5.89%
3 Month
-3.58%
-3.58%
6 Month
-9.58%
-9.58%
1 Year
-15.60%
-15.60%
More News
Read More
QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer
October 26, 2023
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Analyst Expectations for Qiagen's Future
October 17, 2023
Via
Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
Via
Benzinga
Exposures
COVID-19
Will Chart Analysts Notice Bad Omen on Qiagen's Chart
April 11, 2023
Via
Benzinga
Will Investors Notice Exciting Sign On Qiagen's Chart?
December 20, 2022
Via
Benzinga
Earnings Scheduled For October 30, 2023
October 30, 2023
Via
Benzinga
Preview: Qiagen's Earnings
October 27, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
Via
Benzinga
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
July 26, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
Via
Benzinga
The 3 Most Promising Biotech Stocks to Buy Now
March 21, 2023
Via
InvestorPlace
QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results
March 13, 2023
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug
March 09, 2023
From
QIAGEN N.V.
Via
Business Wire
QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing
March 01, 2023
From
QIAGEN N.V.
Via
Business Wire
QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework
February 14, 2023
From
QIAGEN N.V.
Via
Business Wire
QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups
February 07, 2023
From
QIAGEN N.V.
Via
Business Wire
Genetic Technologies Shares Jump After Strategic Alliance With Qiagen
February 01, 2023
Via
Benzinga
QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs
January 17, 2023
From
QIAGEN N.V.
Via
Business Wire
QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast
January 17, 2023
From
QIAGEN N.V.
Via
Business Wire
Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories
January 09, 2023
Via
Benzinga
QIAGEN Acquires Verogen Strengthening Its Position In Human ID / Forensics
January 09, 2023
Via
Benzinga
QIAGEN Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics With NGS Technologies
January 09, 2023
From
QIAGEN
Via
Business Wire
QIAGEN and Helix Launch Exclusive Partnership to Advance Next-Generation Sequencing Companion Diagnostics in Hereditary Diseases
January 05, 2023
From
QIAGEN N.V.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.